C

    Carlsmed, Inc. Common Stock (CARL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $16.29
    -0.59 (-3.50%)

    Market Cap: $444.76M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(4/6)
    Avg Surprise
    +2.21%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.39
    Range$-0.41 - $-0.36
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.40-2.6%
    60d ago$-0.40-2.6%
    30d ago$-0.40-2.6%
    7d ago$-0.40-2.6%
    Current$-0.39
    Revenue Consensus
    $19M
    Range$18M - $20M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.24
    Range$-0.28 - $-0.20
    2 analysts
    Revenue Consensus
    $25M
    Range$24M - $25M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.24---
    Sep 26EST
    		-$-0.39---
    Jun 26
    Reported Jul 21
    		$-0.39$-0.40+2.50%Beat+71.5%
    Mar 26
    Reported May 5
    		$-0.26$-0.39+33.33%Beat+0.0%
    Dec 25
    Reported Feb 25
    		$-0.32$-0.35+7.51%Beat-
    Sep 25
    Reported Nov 6
    		$-0.37$-0.49+24.49%Beat-
    Jun 25
    Reported Aug 28
    		$-1.37$-0.91-50.55%Miss-
    Mar 25
    Reported Jun 26
    		$-0.26$-0.25-4.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio-12.12EV/EBITDAN/A
    Price/FCF-12.42xFCF Yield-8.05%
    Profitability
    Profit Margin-57.40%Operating Margin-58.30%
    ROE-66.10%ROIC-34.61%
    Financial Health
    Debt/Equity0.18xInterest Coverage-25.81x
    Current Ratio8.84xQuick Ratio8.66x
    Trading Statistics
    BetaN/AAvg Volume173.72K
    52-Week High$17.2352-Week Low$8.50

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$16.09
    SMA 20$14.94
    SMA 50$12.94
    SMA 200$12.07
    EMA 10$15.94
    EMA 20$15.07
    EMA 50$13.52
    EMA 200$12.42

    MACD

    Line: 1.11Signal: 1.01Hist: 0.10

    ADX

    ADX: 45.8+DI: 32.1-DI: 11.2

    Aroon & PSAR

    Aroon Up76.0
    Aroon DownN/A
    PSAR$15.98

    Bollinger Bands

    Upper Band$17.47
    Lower Band$12.40
    %B Position3390%(Upper)
    Band Width0.77

    RSI (14-Day)

    Neutral
    66.8

    Momentum Oscillators

    Stoch %K85.0
    Stoch %D82.1
    Williams %R-23.9
    ROC (10d)18.2%
    Momentum2.51
    CCI (20d)87.4
    MFI (14d)76.8

    Volatility Measures

    ATR (14d)$0.81(5.0%)
    StdDev (20d)1.27
    Hist Vol47.9%(High)

    Volume Flow

    VWAP$16.38
    OBV909.0K
    AD Line-1.1M
    CMF (20d)0.220

    Volume Metrics

    Avg Vol (20d)172.5K
    Vol Ratio0.6x
    VWMA (20d)$15.04

    Pivot Points

    R3$17.56
    R2$17.28
    R1$17.08
    Pivot Point$16.80
    S1$16.60
    S2$16.32
    S3$16.12

    Advanced Oscillators

    TSI41.52
    Ultimate Osc52.2
    KST298.04

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$18.94M$16.12M$15.16M$13.07M$12.08M$10.19M$9.41M$6.59M$6.08M$5.09M$4.34M
    Cost of Revenue$4.40M$3.69M$3.56M$3.15M$3.21M$2.55M$2.38M$1.79M$1.52M$1.42M$1.22M
    Gross Profit$14.54M$12.43M$11.61M$9.93M$8.87M$7.64M$7.02M$4.80M$4.56M$3.66M$3.12M
    Operating Expenses$25.58M$21.70M$26.64M$18.96M$15.37M$13.36M$50.57M$12.57M$10.88M$8.99M$8.55M
    R&D$6.04M$5.18M$5.26M$4.45M$4.16M$3.15M$3.02M$4.04M$4.00M$3.26M$0
    SG&A$7.62M$6.23M$4.85M$4.91M$3.34M$3.47M$2.33M$1.92M$2.01M$2.14M$0
    Operating Income$-11,036,000$-9,276,000$-15,037,000$-9,035,000$-6,502,000$-5,719,000$-43,547,000$-7,777,000$-6,319,000$-5,329,000$-5,432,000
    Interest Income$839,000$891,000$1.03M$954,000$336,000$380,000$410,000$394,000$428,000$98,000$0
    Interest Expense$313,000$311,000$687,000$380,000$363,000$357,000$378,000$402,000$325,000$216,000$107,000
    Income Before Tax$-10,510,000$-8,696,000$-14,926,000$-8,526,000$-6,766,000$-5,729,000$-4,720,000$-7,813,000$-6,277,000$-5,447,000$-5,539,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-10,510,000$-8,696,000$-9,197,000$-8,526,000$-6,766,000$-5,729,000$-4,720,000$-7,813,000$-6,277,000$-5,447,000$-5,539,000
    EBITDA$-10,906,000$-9,177,000$-14,141,000$-9,018,000$-6,678,000$-5,712,000$-4,305,000$-7,772,000$-6,380,000$-5,289,000$-5,539,000
    EBIT$-11,036,000$-9,276,000$-14,239,000$-9,100,000$-6,739,000$-5,752,000$-4,342,000$-7,805,000$-6,380,000$-5,329,000N/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CARL

    News

    Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL

    Jupiter Topco LLC recently acquired a significant new holding of 1,251,616 shares in Carlsmed, Inc. ($CARL) during the second quarter, valued at approximately $12.99 million. This acquisition represents about 4.58% of the company's stock. Analysts generally maintain a "Moderate Buy" rating for Carlsmed, with an average price target of $19.25, despite the company reporting an adjusted loss of $0.39 per share for the quarter, though this slightly beat estimates.

    MarketBeat•8/30/26•
    Somewhat-Bullish

    Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL

    Parkman Healthcare Partners LLC has acquired a new stake of 597,318 shares in Carlsmed, Inc. (NASDAQ:CARL) valued at approximately $6.2 million, representing about 2.19% of the company. Several other institutional investors also increased their holdings in Carlsmed. The company reported quarterly revenue of $18.94 million and an adjusted loss of $0.39 per share, slightly beating estimates, and analysts currently rate the stock as a "Moderate Buy" with an average price target of $19.25.

    MarketBeat•8/25/26•
    Somewhat-Bullish

    Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts

    Carlsmed, Inc. (NASDAQ:CARL) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $19.25. The company recently reported quarterly revenue of $18.94 million and an adjusted EPS loss of $0.39, exceeding analyst expectations slightly. Institutional investors have shown increased interest, with significant new positions initiated by Jupiter Topco, Parkman Healthcare Partners, and BlackRock during the second quarter.

    MarketBeat•8/22/26•
    Somewhat-Bullish

    Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales

    Carlsmed Inc. (CARL) has filed a shelf registration to offer up to $250 million in common stock, preferred stock, debt securities, warrants, and units. This filing allows the medical technology company to access capital markets for future funding, with specific terms for each issuance to be detailed in subsequent prospectus supplements. The company, known for its AI-enabled personalized spine surgery solutions, emphasizes that this S-3 filing creates future issuance capacity and is not an immediate sale or dilution of shares.

    Stock Titan•8/14/26•
    Neutral

    CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data

    CARL AI-driven personalized spine surgery platform is experiencing rapid adoption due to strong clinical outcomes and a large U.S. market opportunity exceeding $10 billion. The company anticipates accelerated growth and profitability by 2027, driven by new reimbursement codes, margin expansion, and scalable infrastructure. This information is based on an audio transcript from the Bank of America SMID Cap Virtual Conference involving Carlsmed, Inc. [CARL].

    TradingView•8/12/26•
    Bullish

    Frequently Asked Questions About CARL

    Does CARL pay dividends?
    Carlsmed, Inc. Common Stock (CARL) does not currently pay a regular dividend.
    What is CARL's market cap?
    Carlsmed, Inc. Common Stock (CARL) has a market capitalization of $444.76M with a current stock price of $16.29.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In